← SynDRA
Cligosiban
SynDRA canonical compound SYN0048462 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | AVPR1A | OXT | OXTR |
| Mechanism of action | oxytocin receptor antagonist |
All known targets
Mechanisms of action (all sources)
- oxytocin receptor antagonist
- AVPR1A INHIBITOR
- OXTR INHIBITOR
Cross-references
Synonyms
- CHEMBL594828
- PF-3274167
- PF3274167
- PF 3274167
- UNII-D361S17AIF
- D361S17AIF
- 5-(3-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-5-(methoxymethyl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridine
- Cligosiban [INN]
- 5-{3-[3-(2-chloro-4-fluorophenoxy)azetidin-1-yl]-5-(methoxymethyl)-4H-1,2,4-triazol-4-yl}-2-methoxypyridine
- SCHEMBL4126605
- EX-A297
- MolPort-044-567-557
- BCP08878
- ZINC38239529
- BDBM50305506
- AKOS030526977
- CS-5337
- HY-15023
- B5924
- J-690387
- Pyridine, 5-(3-(3-(2-chloro-4-fluorophenoxy)-1-azetidinyl)-5
- cligosibanum
- RefChem:126965
- MFCD25976681
- PF-3274167cligosiban?
- orb1304299
- SCHEMBL29766734
- SCHEMBL30389498
- GTPL13229
- EBC-521180
- AC-35995
- FP103319
- TS-08759
- T3347
- BRD-K31417912-001-01-9
Look up Cligosiban in the interactive SynDRA portal →